It’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to corruption charges, the issues that American pharmaceutical companies face today...
Read More
Insights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced...
Read More
In late 90s, internet solved the problem of data access. Then came the explosion of data with the web search and social media. Necessity to find relevant data & analyse...
Read More
Leader in Pharmaceutical Research AI expands North American Presence. HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ -- Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today...
Read More
Eschborn, 5th May 2018 – Innoplexus AG supports the World Health Organization (WHO) and the Global Sepsis Alliance (GSA) by measuring the effect of its online and social media communication...
Read More
Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. In December 2017, Amazon, JPMorgan Chase and Berkshire Hathaway announced the formation of a new healthcare...
Read More
As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain is quickly increasing in interest and has received praise for...
Read More
April 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a "2018 TiE50 Finalist" for the prestigious TiE50 Awards Program recognizing the world's...
Read More
Insights into the Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance & Management On June 18, 2018, the first annual AI summit...
Read More
Post Written By Gunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has skyrocketed, but disruptive technologies can bring it back down to...
Read More
